Economy

Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries Limited (TEVA)”

During last 3 month period, 1.85% of total institutional ownership has changed in the company shares. Teva Pharmaceutical Inds Ltd now has $17.88 billion valuation. After a recent check, it is observed that the insiders for the firm now own 2.70% shares. It is down 81.36% since September 19, 2016 and is uptrending. It has outperformed by 7.27% the S&P500.

Yesterday Teva Pharmaceutical (NYSE:TEVA) traded -1.42% lower at $16.96. The lowest price the stock reached in the last trading day was $11.65 and compares with the $6.7 52-week low. The institutional investor held 23,640 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $857,000, down from 47,395 at the end of the previous reported quarter. The firm has "Underperform" rating by RBC Capital Markets given on Monday, September 18. The stock rose 1.38% or $0.23 reaching $17.23.

T2 Biosystems, Inc. (NASDAQ:TTOO) trade at $4.58 by jumped up 1.26% in most recent trading session with share volume of 246794.

Teva Pharmaceutical Industries Limited (TEVA) belonging to the Healthcare sector has declined -6.13% and closed its last trading session at $16.99. It has underperformed by 58.40% the S&P500. After posting $0.99 EPS for the previous quarter, Teva Pharmaceutical Industries Ltd (ADR)'s analysts now forecast 6.06 % EPS growth. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.06 by ($0.07). Equities research analysts expect that Teva Pharmaceutical Industries Limited will post $4.32 EPS for the current fiscal year. Edge Asset Management, Inc claims 908,603 shares worth $29,157,000. Next Financial Group, Inc augmented its holdings by buying 6,350 shares an increase of 150.3%.

More notable recent Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) news were published by: Investorplace.com which released: "Battered Teva Pharmaceutical Industries Ltd (ADR) Stock Still Is Toxic" on August 29, 2017, also Investorplace.com with their article: "Go Long Teva Pharmaceuticals Industries Ltd (ADR) (TEVA) Stock With Less ..." published on September 14, 2017, Benzinga.com published: "A Look At Teva's Paragard IUD Asset Sale To Cooper Companies, From Both Sides" on September 13, 2017. T2 Biosystems has granted the underwriters a 30-day option to purchase up to an additional 656,250 shares of common stock at the public offering price, less the underwriting discount. On August 16 the stock rating was downgraded to "Neutral" from "Buy" by analysts at Citigroup. Therefore 28% are positive. Finally, Maxim Group reissued a hold rating and issued a $35.00 price objective on shares of Teva Pharmaceutical Industries Limited in a research report on Thursday, July 13th.

09/13/2017 - Teva Pharmaceutical Industries Limited had its "hold" rating reiterated by analysts at Maxim Group. The value of the company's investment in Teva Pharmaceutical Industries decreased from $11,751,000 to $9,479,000 a change of $2,272,000 since the last quarter. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned "Market Perform" rating by Bernstein on Friday, August 4.

On August 7 Barclays maintained a company rating of "Equal-Weight" and lowered the price expectation to $23.00 from $46.00.

Teva Pharmaceutical Industries Limited (TEVA) failed to surprise the stock market in its last reported earnings when it earned $1.02 a piece versus the consensus-estimated $1.06. As per Thursday, August 31, the company rating was upgraded by Argus Research. As of December 31, 2016, the Company had a global portfolio of over 1,800 molecules.

Among 14 analysts covering ABB Ltd (NYSE:ABB), 7 have Buy rating, 2 Sell and 5 Hold. Gilead Sciences had 89 analyst reports since July 29, 2015 according to SRatingsIntel. On Thursday, April 21 the stock rating was maintained by Robert W. Baird with "Neutral". The rating was downgraded by JP Morgan on Tuesday, September 22 to "Underweight". On Tuesday, September 12 the stock rating was maintained by Jefferies with "Hold". The rating was upgraded by RBC Capital Markets on Wednesday, January 25 to "Outperform". The firm has "Buy" rating by BTIG Research given on Monday, September 11. Mizuho has "Buy" rating and $64.0 target.



Like this

Latest


19 September 2017
Spain Expels N. Korean Ambassador
It carried out its sixth and most powerful nuclear test earlier this month, and fired a long-range ballistic missile over Japan that landed in the Pacific.

19 September 2017
Melbourne grandmother dies on Thai holiday
An Melbourne woman on holiday in Thailand with her family has died while swimming at a beach in the resort town of Phuket . Police said they were told the couple ignored signs warning them not to swim in the water.

19 September 2017
Parsons Green tube bomb 'built in garden shed'
British police said earlier they were keeping an open mind on whether more than one person was responsible for the bombing. Police officers on the scene during a search on an address in Stanwell on September 17, 2017 in London, England.

19 September 2017
Palo Alto Networks, Inc. (NYSE:PANW) Closed Over Its 50 Day Average
Susquehanna Group Inc Limited Liability Partnership owns 0% invested in Brooks Automation, Inc (NASDAQ:BRKS) for 155,403 shares. Wellington Shields Capital Mngmt Ltd Llc has 9,475 shares for 0.2% of their portfolio. 13,920 were reported by Kcm Inv Limited.

19 September 2017
CareTrust REIT, Inc. (NASDAQ:CTRE) Trading Up - Short Interest decreased by -7.16%
BMO Capital Markets has downgraded Caretrust REIT Inc (NASDAQ: CTRE ) to Market Perform in a report released on 6/20/2017. State of Alaska Department of Revenue increased its position in shares of CareTrust REIT by 4.6% during the 1st quarter.

19 September 2017
Gibson focused on 'taking the Proteas back to the top'
There's no need for me to go into that because it's happening already as far as selection is concerned. On team selection, Gibson suggested he would have a limited role.

19 September 2017
Analyst Research Roundup: Bob Evans Farms, Inc. (BOBE), AnaptysBio, Inc. (ANAB)
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 5.95, and a price to sales ratio of 49.93. Its up 0.10, from 0.99 in 2016Q3. 385.64 million shares or 1.20% less from 390.31 million shares in 2016Q3 were reported.

19 September 2017
Eldorado Gold Corporation Ordin (NYSE:EGO) Trading Volume Significantly Higher
Finally, Sumitomo Mitsui Trust Holdings Inc. increased its position in Eldorado Gold Corporation by 2.0% during the first quarter. Short traders are more bearish on shares of the company of late if you take a look at the increase in short interest.

19 September 2017
Red Bull and Renault brush off engine 'speculation'
Media reports have suggested Aston could become Red Bull's title sponsor next season. They already said that it's not Porsche.

19 September 2017
Horizon Zero Dawn Update Patch 1.33 Notes Have Been Released
Killing the Corruptor will block the progression of the story as players can not interact with it anymore. Fixed an issue where some players were able to reroll Special Modification Boxes by saving and reloading.



Recommended